To further confirm whether the accelerated degradation of ATMIN upon USP10-knockdown depends on the ubiquitin-proteasome pathway or the lysosomal pathway, NPC cells were treated with proteasome inhibitor MG132 or lysosome inhibitor CQ after USP10-knockdown. The gene discussed is USP10; the disease is nasopharyngeal carcinoma.